Recent advances in Clostridium difficile-associated disease

被引:77
作者
Monaghan, T. [1 ,2 ,3 ]
Boswell, T. [2 ,4 ]
Mahida, Y. R. [1 ,2 ,3 ]
机构
[1] Univ Nottingham, Inst Infect Immun & Inflammat, Nottingham NG7 2UH, England
[2] Nottingham Univ Hosp NHS Trust, Nottingham NG7 2UH, England
[3] Univ Nottingham, Div Gastroenterol, Nottingham NG7 2UH, England
[4] Univ Nottingham, Dept Clin Microbiol, Nottingham NG7 2UH, England
关键词
IN-VITRO ACTIVITY; ANTIBIOTIC-ASSOCIATED DIARRHEA; TOXIN-BINDING POLYMER; INTRAVENOUS IMMUNOGLOBULIN; DOUBLE-BLIND; RISK-FACTORS; PSEUDOMEMBRANOUS COLITIS; REDUCED SUSCEPTIBILITY; ENTERIC INFECTION; CONTROLLED-TRIAL;
D O I
10.1136/gut.2007.128157
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The main purpose of this article is to review recent developments in the management of acute and recurrent Clostridium difficile-associated disease, with consideration of existing and new antibiotic and non-antibiotic agents for treatment. Details of the current developmental stage of new agents are provided and the role of surgery in the management of severe disease is discussed. Infection control measures considered comprise prudent use of antimicrobials, prevention of cross-infection and surveillance. Other topics that are covered include the recent emergence of an epidemic hypervirulent strain, pathogenesis, clinical presentation and approaches to rapid diagnosis and assessment of the colonic disease.
引用
收藏
页码:152 / 162
页数:11
相关论文
共 143 条
  • [1] Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube
    Aas, J
    Gessert, CE
    Bakken, JS
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) : 580 - 585
  • [2] In vitro activity of OPT-80 against clostridium difcile
    Ackermann, G
    Löffler, B
    Adler, D
    Rodloff, AC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) : 2280 - 2282
  • [3] Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea
    Alfa, MJ
    Kabani, A
    Lyerly, D
    Moncrief, S
    Neville, LM
    Al-Barrak, A
    Harding, GKH
    Dyck, B
    Olekson, K
    Embil, JM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) : 2706 - 2714
  • [4] CLOSTRIDIUM-DIFFICILE INFECTION ASSOCIATED WITH ANTINEOPLASTIC CHEMOTHERAPY - A REVIEW
    ANAND, A
    GLATT, AE
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 17 (01) : 109 - 113
  • [5] [Anonymous], 1995, INFECT CONT HOSP EP, V16, P105
  • [6] Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis:: Case series and review of the literature
    Apisarnthanarak, A
    Razavi, B
    Mundy, LM
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (06) : 690 - 696
  • [7] Treatment of Clostridium difficile-associated disease:: old therapies and new strategies
    Aslam, S
    Hamill, R
    Musher, DM
    [J]. LANCET INFECTIOUS DISEASES, 2005, 5 (09) : 549 - 557
  • [8] Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters
    Babcock, Gregory J.
    Broering, Teresa J.
    Hernandez, Hector J.
    Mandell, Robert B.
    Donahue, Katherine
    Boatright, Naomi
    Stack, Anne M.
    Lowy, Israel
    Graziano, Robert
    Molrine, Deborah
    Ambrosino, Donna M.
    Thomas, William D., Jr.
    [J]. INFECTION AND IMMUNITY, 2006, 74 (11) : 6339 - 6347
  • [9] A European survey of diagnostic methods and testing protocols for Clostridium difficile
    Barbut, F
    Delmée, M
    Brazier, JS
    Petit, JC
    Poxton, IR
    Rupnik, M
    Lalande, V
    Schneider, C
    Mastrantonio, P
    Alonso, R
    Kuipjer, E
    Tvede, M
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (10) : 989 - 996
  • [10] Review article: tolevamer, a novel toxin-binding polymer: overview of preclinical pharmacology and physicochemical properties
    Barker, R. H., Jr.
    Dagher, R.
    Davidson, D. M.
    Marquis, J. K.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (11-12) : 1525 - 1534